Long-term treatment of hereditary angioedema with attenuated androgens: A survey of a 13-year experience

The Journal of Allergy and Clinical Immunology

Volumn 87, Issue 4, 1991, Pages 768-773

  Cicardi, Marco ^a   Bergamaschini, Luigi ^a   Cugno, Massimo ^a   Hack, Erik ^a   Agostoni, Giovanni ^a   Agostoni, Angelo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; STANOZOLOL;

ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; FEMALE; HUMAN; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIONEUROTIC EDEMA; ANTIGENS; CHILD; CHILD, PRESCHOOL; COMPLEMENT 1 INACTIVATORS; COMPLEMENT 4; DANAZOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; MALE; MIDDLE AGE; STANOZOLOL; SUPPORT, NON-U.S. GOV'T;

EID: 0025874826     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(91)90120-D     Document Type: Article

References (37)

1. A biochemical abnormality in hereditary angioneurotic edema
2. Plasma levels of C1 inhibitor complexes and cleaved C1 inhibitor in patients with hereditary angioneurotic edema
3. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema
4. Response of variant hereditary angioedema phenotypes to danazol therapy
5. Altered C1 inhibitor genes in type 1 hereditary angioedema
6. Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema
7. Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements
8. Genetic heterogeneity of hereditary angioneurotic edema
9. Type 1 C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon
10. CpG mutations in the reactive site of human C1 inhibitor
11. 444His) mutation
12. Type II hereditary angioneurotic edema may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene
13. Hereditary angioedema: the clinical syndrome and its management
14. Hereditary angioedema: an appraisal of 104 cases
15. Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities
16. Remission induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1 inhibitor and the fourth and second component of complement
17. Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema
18. A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens
19. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease
20. Danazol for the treatment of idiopathic thrombocytopenic purpura
21. Danazol increases factor VIII and factor IX in classical hemophilia and Christmas disease
22. Effect of danazol on coagulation parameters and bleeding in hemophilia
23. Danazol for the treatment of idiopathic thrombocytopenic purpura
24. Treatment of hereditary protein C deficiency with stanozolol
25. Effect of danazol in immune thrombocytopenic purpura
26. Liver damage from long-term methyltestosterone
27. Hepatic angiosarcoma associated with androgenic anabolic steroids
28. Long-term therapy of hereditary angioedema with danazol
29. Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives
30. Danazollangzeittherapie bei hereditarem angioodem
31. Immunochemical quantitation of antigens by immunodiffusion
32. A C1-Inhibitor complex assay (INCA): a method to detect C1 activation in vitro and in vivo
33. Proteolytic inactivation of plasma C1 inhibitor in sepsis
34. An investigation of the materno-fetal hormonal milieu with special emphasis on the maternal influence
35. Une cause meconnue de polyglobulie: le traitement anabolisant prolongé
36. Hereditary angioneurotic oedema and pregnancy: case reports and review of the literature
37. Plasma levels of C1 inhibitor complexes and modified inactive C1 inhibitor in hereditary angioedema [Abstract]